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Received January 20, 2010; accepted July 25, 2010AbstractBackground: Pelvic irradiation has been a popular therapy modality for cervical cancer for many years, and its usage in rectal cancer and prostate
cancer cases is on the rise. However, it is associated with significant side effects. In this study, we compared the different characteristics of
surgical and nonsurgical patients who were treated for radiation enterocolitis, the treatment results, posttreatment quality of life (QOL), nutrition
status, and predisposing factors for surgery.
Methods: From 1985 to 2009, the records of a total of 89 patients with chronic radiation enterocolitis in our hospital were retrospectively
reviewed for demographic data, operative data and long-term treatment results. Posttreatment QOL and nutrition status were also recorded.
Univariate and multivariate analyses were performed to identify the independent predicting factors associated with surgical intervention.
Characteristics of surgical and nonsurgical patients were compared.
Results: Radiotherapy before 1995, concomitant radiation uropathy and smoking were independent predictive factors for surgery. Surgical and
nonsurgical cases had similar KaplaneMeier curves. Although the recurrence rate of radiation enterocolitis was much higher for the surgical
group ( p ¼ 0.031), both groups had similar QOL score (median: 8 vs.7; p ¼ 0.709), serum albumin level (3.29 g/dL vs. 3.16 g/dL; p ¼ 0.095),
and body mass index (20.19 vs. 19.86; p ¼ 0.603).
Conclusions: We confirmed that as compared with recently developed innovative techniques, early primitive radiotherapy techniques were
associated with more severe radiotherapy complications that required surgery. Smoking may enhance patients’ vulnerability to severe radiation
injury. Surgery for radiation-induced intestinal obstruction, intestinal fistula and perforation is warranted because QOL, serum albumin level and
body mass index were similar between the surgical and nonsurgical groups.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Radiotherapy for locally advanced gynecological, rectal and
prostate malignancies is on the rise, with proven efficacy.
However, it is associated with significant side effects. Radiation
enterocolitis, especially chronic radiation enterocolitis, is the
most dreaded side effect of radiotherapy. Unlike acute radiation
enterocolitis, which is a transient and self-limited disease,1,2
chronic radiation enterocolitis usually manifests with an* Corresponding author. Dr. Hwei-Ming Wang, Division of Colorectal
Surgery, Department of Surgery, Taichung Veterans General Hospital, 160,
Section 3, Chung-Kang Rd., Taichung 407, Taiwan, ROC.
E-mail address: henry_chen@vghtc.gov.tw (H.-M. Wang).
1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.01.014irreversible and progressive disease pattern with variable gastro-
intestinal manifestations.3,4 The latency period from radio-
therapy to onset of radiation enterocolitis is also variable, ranging
from 3 months to 30 years.5 The prognosis for chronic radiation
enterocolitis is unpredictable. Some patients enjoy sustained
remission under proper medical treatment, although others
experience progression of radiation enterocolitis to such an
extent that surgery is required.6 Recurrence after treatment is
common.7 Iraha et al. identified three risk factors for surgery:
smoking, diabetes mellitus and abdomino-pelvic surgery.8 In the
literature, about 20e40% of patients with these risk factors died
of radiation injury. 6,9,10 Fortunately, many radiation techniques,
such as three-dimensional conformal radiotherapy, greatlyhinese Medical Association. All rights reserved.
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Novel therapeutic modalities, such as hyperbaric oxygen therapy
(HBOT),11,12 formalin instillation and prostaglandin E1(PGE1)
infusion,13,14 were developed to treat radiation enterocolitis after
2000. As such, the disease patterns and outcomes of patients may
have been altered by advances in technology. In this study, we
retrospectively analyzed singlecenter cases of chronic radiation
enterocolitis in the past 25 years to establish a Taiwanese data-
base of patients characteristics, disease patterns and treatment
results. In addition, we identified predictive factors associated
with development of surgical conditions. The quality of life
(QOL) and nutrition status of patients after surgical and
nonsurgical treatment were also compared.
2. Methods2.1. PatientsTaichung Veterans General Hospital (TCVGH) is a tertiary
referral center in central Taiwan. Cases in areas including
Nantou, Chiayi, Yunlin, Miaoli and Changhwa were included.
From 1985 to 2009, all patients whowere treated for radiation
enterocolitis in our radiation oncology department, surgical
department, medical department, gynecology department and
hyperbaric oxygen therapy unit (launched in June 2003) were
retrospectively evaluated for eligibility. To be included in the
study, the patient was required to meet at least one of the
following criteria: (1) pathologist diagnosis of radiation
enterocolitis according to surgical specimen, (2) pathologist
diagnosis of radiation enterocolitis according to specimen
obtained from colonoscopy biopsy, or (3) no biopsy was
obtained, but the colonoscopy features were compatible with
radiation colitis or the onset of symptoms had a clear chrono-
logical relationship to that of radiotherapy. To exclude cases of
acute radiation enterocolitis, the latency period had to be longer
than 10 months.5,15 A retrospective review of medical records
was performed for demographic data, details of operation,
manifestation of radiation enterocolitis, treatment course and
comorbidities. The latency period of radiation enterocolitis was
recorded as the period from termination of radiotherapy to the
time when the disease was diagnosed. The cancer status (no
evidence of disease or uncured), radiation dosage and previous
abdomino-pelvic surgery were also recorded.2.2. Follow-upThe long-term outcomes were evaluated carefully. Survival
status and disease status of radiation enterocolitis were eval-
uated by reviewing the medical database reinforced by tele-
phone follow-up to all the patients who received no regular
postoperative outpatient department examinations for more
than 3 months.2.3. Surgical and nonsurgical casesAll the cases were assigned into either nonsurgical group or
surgical group according to whether or not surgical interventionwas performed. The characteristics of nonsurgical and surgical
patients including demographics, radiation dosage, presenting
symptoms, latency period, cancer status, remission and recur-
rence of symptomatic radiation enterocolitis, and presence of
concomitant radiation uropathy were recorded and compared.
The parameters of posttreatment nutrition status, such as serum
albumin level and body mass index, were recorded retrospec-
tively at about 1 year after treatment for both groups of patients.
For surgical patients, surgical mortality and surgical compli-
cations which have long-lasting effect on life quality (short
bowel syndrome, enterocutaneous fistula, ventral hernia,
pulmonary insufficiency which required long-time mechanical
ventilation) were recorded.2.4. Predicting factors for surgeryPredicting factors associated with surgery for radiation
enterocolitis were evaluated. Following the series of Iraha
et al,8 we analyzed history of diabetes mellitus, smoking and
abdomino-pelvic surgery as possible predisposing factors.
Because HBOT was believed to enable conversion of possible
surgical cases into nonsurgical cases, we analyzed “treatment
before the HBOT era” as a predisposing factor. Early primitive
radiotherapy was also analyzed as a possible predisposing
factor. Furthermore, all factors that were found to be associated
with surgery in the cross-group comparison were subjected to
univariate and multivariate analyses.2.5. QOL evaluationIn June 2010, each patient who survived at that time point
was evaluated for life quality. We adapted the QOL scoring
system for abdominal surgery from the Journal of the American
College of Surgeons (supplemental Table 1).25 The scoring
system uses a 12-point scale, with 12 indicating the best QOL
status and 0 indicating the worst QOL.2.6. Statistical analysisAll statistical analyses were performed using SPSS 16.0 for
Windows (SPSS Inc., Chicago, IL, USA). Fisher’s exact test was
used to compare categorical variables, although continuous
variables were compared with the ManneWhitney U test.
Overall survival rates were estimated by the Kaplane
Meier method. Survival curves were statistically compared
using the log-rank test. Variables with p < 0.1 in univariate
analysis were subjected tomultivariate Cox regressionmodeling
using backward stepwise variable selection. A two-tailed p value
of <0.05 was considered statistically significant for all tests.
3. Results3.1. Comparison between surgical and nonsurgical
patientsA total of 89 patients who were diagnosed as radiation
enterocolitis between 1985 and 2009 inTCVGHwere enrolled in
Table 1
Characterization of surgical and nonsurgical patients
Surgical
(n ¼ 35)
Nonsurgical
(n ¼ 54)
p
Age, yr 65.09 10.11 61.61 15.08 *0.011d
Female, % 27 (77.14) 33 (66.11) 0.083a
Median radiation
dosage, cGy
5,120 2,908 5,075 3,262 0.152d
Median latency period, mo 17.08 98.45 8.59 76.59 *0.037d
Gynecological malignancy 26 (74.29) 22 (40.74) *0.002a
Manifestation number *<0.0001a
Obstruction 13 (37.14) 1 (1.85)
Fistula 10 (28.57) 0
Bleeding 7 (20.00) 36 (66.67)
Perforation 5 (14.28) 0
Enterocolitis 0 17 (31.48)
Uncured cancer (%) 25.70 59.20 *0.002b
Presence of radiation
uropathy
19 (54.28) 7 (12.96) *<0.0001b
Survive 20 (57.14) 25 (46.29) 0.434b
Symptom free 22 (66.85) 47 (87.03) *0.016b
Abdomino-pelvic
operation
23 (65.71) 25 (46.29) 0.085b
Biopsy-proved radiation
enterocolitis
27 (77.14) 36 (66.67) 0.354b
Treatment before the
era of OCPT
15 (42.85) 9 (16.67) *0.014b
Older age > 65 yr 21 (60.00) 23 (42.59) 0.132a
Smoking 4 (12.90) 9 (16.66) 0.555c
Diabetes mellitus 4 (11.42) 18 (14.81) 0.65c
Uremia 1 (2.86) 2 (3.7) 0.829c
Received HBO therapy 2 (5.71) 4 (7.40) 0.644c
Radiation related death 10 (28.5) 7 (12.96) 0.553b
a Yate’s correction of contingency.
b Fisher’s exact test.
c Peason’s chi-square test.
d ManneWhitney U test.
Data are presented as mean  standard or n (%).
HBO ¼ hyperbaric oxygen; OCPT ¼ hyperbaric oxygen therapy;
SD ¼ standard deviation.
Table 2
Differences in latency period of symptoms
Symptom Mean latency in months (SD) p
1. Obstruction & fistula 95.15 (109.88) <0.0001a
2. Perforation & bleeding 39.95 (79.00) 0.019b
3. Chronic diarrhea 12.10 (33.24) 0.04c
a KruskaleWallis test
b ManneWhitney U test, 1 and 2
c ManneWhitney U test, 2 and 3.
SD ¼ standard deviation.
Table 3
Univariate analysis of factors associated with operation for enterocolitis
Risk factors p
Older age > 65 yr 0.04**
Radiotherapy before 1985 0.099*
Radiotherapy before 1995 0.029**
Treatment before the era of HBOT 0.009**
Symptom of obstruction or fistula 0.026**
Uncured cancer 0.473
Gynecological malignancy 0.96
Diabetes mellitus 0.721
Smoking 0.025**
Abdomino-pelvic operation 0.136
Uremia 0.696
Radiation uropathy 0.053*
Latency > 5 yr 0.424
Radiation dose > 7,000 cGy 0.588
Radiation dose > 9,000 cGy 0.872
OCPT ¼ hyperbaric oxygen therapy.
*p < 0.1 ¼ **p < 0.05 by log-rank test.
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radiation enterocolitis, although 54 patients had medical treat-
ment only. As compared with nonsurgical patients, surgical
patients were significantly older in age ( p¼ 0.011), had a longer
latency period ( p ¼ 0.037), and were associated with a higher
percentage of gynecological malignancies ( p¼ 0.002). Surgical
cases manifested more frequently with symptoms of obstruc-
tion and fistula, although nonsurgical cases manifested mainly
with bleeding and chronic diarrhea ( p < 0.0001). Surgical
cases were more likely to have concomitant radiation uropathy
( p < 0.0001), although nonsurgical cases were more likely to
have uncured cancer ( p ¼ 0.002). Compared with nonsurgical
cases, a higher percentage of surgical cases were diagnosed and
treated before the era of HBOT ( p ¼ 0.014) (Table 1).
The length of the latency period was associated with the
presenting symptom ( p< 0.0001) (Table 2). In cases presenting
with obstruction or fistula, the mean latency period was 95.15
months, which was significantly longer than that for cases with
perforation or hemorrhage (39.95 months) ( p ¼ 0.019). The
cases presenting with chronic diarrhea had the shortest mean
latency period (12.10 months, p ¼ 0.04) (Table 2).In univariate analysis (Table 3), older age > 65 years
( p ¼ 0.04), radiotherapy before 1995 ( p ¼ 0.029), diagnosed
as having radiation enterocolitis before the era of HBOT
( p ¼ 0.009), symptom of obstruction or fistula ( p ¼ 0.026)
and history of smoking ( p ¼ 0.025) were significantly asso-
ciated with surgical intervention for radiation enterocolitis
(Table 4). Radiotherapy before 1985 ( p ¼ 0.099) and
concomitant radiation uropathy ( p ¼ 0.053) tended to be
associated with operation but without statistical significance.
In multivariate analysis (Table 4), radiotherapy before 1995
( p ¼ 0.022), symptom of obstruction or fistula ( p < 0.0001),
history of smoking ( p ¼ 0.015) and concomitant radiation
uropathy ( p ¼ 0.026) were identified as independent risk
factors associated with surgical intervention in patients with
chronic radiation enterocolitis.3.2. QOL, nutrition status and operative complications
after treatmentThe median QOL score for the surgical group was 8, as
comparedwith 7 for the nonsurgical group ( p¼ 0.709). One year
after treatment, the mean serum albumin level was 3.29 g/dL for
the surgical group and 3.16 g/dL for the nonsurgical group
( p ¼ 0.095). The mean body weight mass index after treatment
was 20.09 for the surgical group and 19.86 for the nonsurgical
group ( p¼ 0.603). The complication rate for surgerywas 22.9%,
and the surgical mortality rate was 5.7% (Table 5).
Table 4
Multivariate analysis of factors associated with surgery for radiation
enterocolitis
Risk factors Hazard ratio
(95%CI)
Standard
error
p
Radiotherapy before
1995
2.898 (1.162e7.246) 0.466 0.022a
Symptom of obstruction
or fistula
3.412 (1.763e6.622) 0.337 <0.0001a
Smoking 4.379 (1.339e14.324) 0.605 0.015a
Concomitant radiation
uropathy
2.332 (1.104e4.926) 0.381 0.026a
a Backward stepwise (Wald).
Fig. 1. Overall survival of surgical and nonsurgical patients following
treatment.
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year survival rate was 54% for surgical cases and 38% for
nonsurgical cases ( p ¼ 0.072) (Fig. 1). Because there were
a significantly higher percentage of patients with uncured
cancer in the nonsurgical group, we analyzed survival curves
stratified by cancer status to avoid the confounding effect of
cancer status. There was no difference in the survival curves
for the two no evidence of disease cases ( p ¼ 0.930) (Fig. 2A)
and the uncured cancer cases ( p ¼ 0.213) (Fig. 2B).3.3. Surgical patients had significantly more recurrences
of radiation enterocolitisThe 5-year and 10-year recurrence rates for the nonsurgical
group were both 18%, suggesting that the recurrence rate
remained steady after 5 years and thereafter for the nonsurgical
group. In contrast, the recurrence rate for surgical patients rose
continually through the 5th to the 10th posttreatment years, being
28% at the 5th year and 52% at the 10th year. The recurrence rate
was significantly higher for surgical patients ( p ¼ 0.031)
(Fig. 3).
4. Discussion
Chronic radiation enterocolitis, a dreaded complication of
radiotherapy with a considerable mortality rate, is currently
receiving more attention because of increasing usage of
radiotherapy in pelvic malignancies.26,27 To our knowledge,Table 5
Life quality, gastro-intestinal function and operative complications after
treatment
Surgical group
(n ¼ 35)
Nonsurgical
group (n ¼ 54)
p
Surgical complication 8 (22.9) 0 0.003b
Surgical mortality 2 (5.7) 0 0.076b
Median quality of life
score
8 0.243 7 0.298 0.709a
Serum albumin (g/dL) 3.29 3.16 0.095a
Body mass index 20.09 19.86 0.603a
a ManneWhitney U test
b Pearson’s chi-square test.
Data are presented as n (%) or median  standard deviation.this is the largest series of chronic radiation enterocolitis cases
in Taiwan which analyzes different characteristics of surgical
and nonsurgical cases, treatment results, posttreatment QOL
and risk factors predisposing to surgical intervention.
The likelihood of developing radiation enterocolitis after
radiotherapy is dosage-dependent. A radiation dosage of
4,000d4,500 cGy is thought to be the triggering factor.16
However, the severity of radiation enterocolitis does not
seem to correlate to radiation dosage.7,9,10 Higher radiation
dosage may not predispose patients to severe radiation
enterocolitis and even surgery.17 Thus, efforts have been made
to identify those patients who are at risk of developing severe
radiation enterocolitis. In the series of Iraha et al, diabetes
mellitus, smoking and previous abdomino-pelvic surgery are
identified as risk factors for surgery.8 In our series, we
confirmed smoking as an independent risk factor associated
with surgery. Recent human and animal studies suggest that
elevated levels of mucosal proinflammatory cytokines such as
interleukin 2, interleukin 6 and tumor-necrosis factor a may be
responsible for vulnerability to radiation enterocolitis.20,21 It is
likely that smoking has an effect on systemic inflammatory
response and hence on elevated proinflammatory cytokines,
making patients more vulnerable to severe radiation injury.
However, this theory requires further investigation.
By identifying radiotherapy before 1995 as an independent
predictor for surgery, we confirmed the long standing belief
that early primitive radiotherapy techniques actually brought
about more complications that required surgery. A series of
innovative radiotherapy techniques developed in the late 1990s
and the early 2000s, such as IMRT (intensity-modulated
radiation therapy), may have effectively reduced the incidence
of severe radiation enterocolitis.
To our knowledge, the association of concomitant radiation
uropathy with surgical condition has not yet been discussed
elsewhere. The existence of concomitant radiation uropathy
Fig. 2. Overall survival of patients stratified by cancer status, stratified by
cancer status. (A) No evidence of disease. (B) With uncured cancer.
Fig. 3. Recurrence of radiation enterocolitis in surgical and nonsurgical
groups.
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radiation injury. In accordance with this possibility, physicians
may encounter a severe radiation injury if radiation uropathy
develops.
The surgical indication for radiation enterocolitis is
changing. There are numerous reports about the success of
HBOT in treatment of hemorrhagic proctitis.11,12 Thus, the
number of surgeries for radiation proctitis is expected to decline
with the availability of HBOT. Total parenteral nutrition and
naso-gastric tube decompression are notoriously ineffective for
intestinal obstruction caused by radiation injury.18,19 Thus, 94%
of such patients require surgery because of the disease’s
progressive and irreversible nature.7 One report in Taiwan also
confirmed this point of view24; thus, conservative treatment is
no longer recommended. For intestinal fistula, the chance of
spontaneous closure is slim because of the poor healing power
of irradiated tissue. Patients with radiation related intestinal
fistula frequently require resection of fistula containing intes-
tine or a diversion procedure to correct this condition.
Once a surgical condition develops, surgical interventionmay
be justified because the survival curves of surgical cases andnonsurgical cases are similar despite the fact that surgical cases
are usually associated with severe symptoms. Although the
recurrence rate for radiation enterocolitis was much higher for
the surgical group, the posttreatment gastro-intestinal tract
function, nutrition status (serum albumin and body mass index)
andQOLscorewere similar in both groups despite usually severe
symptoms in the surgical group, which further justifies operation
in such patient groups. The recurrence rate for the conservative
treatment group was very low and, remarkably, there were very
few cases of recurrence after 5 years for the conservative treat-
ment group. Radiation proctitis and radiation enterocolitis with
chronic diarrhea have a benign nature and are medical diseases
which should not be treated surgically. The fact that surgical
symptoms of obstruction and fistula are associated with
a significantly longer latency period suggests that the irreversible
nature of surgical symptomsmay require longer incubation time.
The pathological findings of surgical specimens from such cases
featured stromal fibrosis and vascular ischemia, which were
irreversible and required surgical correction.35
Recent human and animal studies suggest that radiation
enterocolitis and inflammatory bowel disease may share the
same molecular pathways in pathogenesis.22,23 As such, the
drugs used for inflammatory bowel disease, such as 5-ASA
and tumor-necrosis factor a blocker, may be promising agents
for treatment of radiation enterocolitis.23 Every effort should
be made to prevent radiation injury. We hope that new thera-
peutic and protective agents will be developed to further
reduce the mortality rate of chronic radiation enterocolitis.
In conclusion, radiation enterocolitis is a progressive
disease with an ill-defined nature. We identified smoking,
radiotherapy before 1995, and concomitant radiation uropathy
as independent risk factors associated with surgical interven-
tion. In this series, the surgical group was associated with
a longer latency period than the nonsurgical group. Finally,
surgery may be justified once a surgical condition develops
because surgical cases have similar survival curves, QOL-
scores and nutrition status to those of nonsurgical cases despite
severe symptoms.
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